Sitagliptin Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on the Combination of Metformin and Glimepiride A total of 441 patients with type 2 diabetes participated in a 24-week, randomized, double-blind, placebo-controlled study designed to assess the efficacy of sitagliptin in combination with glimepiride, with or without metformin
Why Duration and Indication Matter in Treatment Selection Phentermine's approval for short-term use reflects decades of evidence focused on acute appetite suppression
Obesity-related healthcare spending averages $1,861 per person per year above healthy-weight peers, in 2019 dollars, according to the CDC
Great Stuff
Reactive tests answer "what's wrong right now." Monitoring tests answer, "what am I at risk of?" Preventative tests answers, what is improving?
Noom Noom is a wellness program based in psychology that on a mission to help people change eating habits (vs